A systematic review to support clinical practice guidelines on the pharmacological versus non-pharmacological treatments of major depressive disorder (MDD). The systematic review is structured in two parts: Part 1: Update of the 2015 Agency for Healthcare Research and Quality (AHRQ) report on pharmacological versus non-pharmacological treatments. Conduct of two rapid reviews on values and preferences of patients with MDD and cost effectiveness of MDD treatments. Part 2: Additional literature searches to build a network meta-analyses model and conduct network meta-analyses of pharmacological versus non-pharmacological treatments.
|Duration||10/06/2020 - 31/03/2022|
|Funding||andere internationale Organisationen|
|Principle investigator for the project (University for Continuing Education Krems)||Univ.-Prof. Dr. Gerald Gartlehner, MPH|
|Project members||Lisa Affengruber, MSc Andrea Chapman, MA BSc Dr. Andreea Dobrescu Emma Persad, BSc Mag. Ana Toromanova Dr. Gernot Wagner|
Nonpharmacological Versus Pharmacological Treatments for Adult Patients with Major Depressive Disorder
ACP CGC Findings Presentation: Depression SR and NMA, 26/01/2022